Low-dose Morphine Improves Health in COPD Patients With …
WEBSep 3, 2020 · by Steve Bryson, PhD September 3, 2020. Regular, low-dose oral morphine led to significant health improvements in adults with advanced chronic obstructive pulmonary disease (COPD) who regularly experienced shortness of breath, according to results of a Phase 4 clinical trial. Treatment with morphine did …
1st approved Symbicort generic, Breyna, now available in US
WEBAug 7, 2023 · The inhaled medication — the first Symbicort generic to be approved by the U.S. Food and Drug Administration — will become immediately available to eligible patients.. Like Symbicort, Breyna is approved as a maintenance therapy to lower airflow obstruction and prevent exacerbations in people with COPD, and for asthma patients, ages 6 …
FDA Approval Sought for New Generic Version of Advair Diskus
WEBApr 8, 2021 · The FDA approved a different generic version of Advair Diskus, called Wixela Inhub and developed by Mylan, now part of Viatris, in 2019. It was the first generic of the inhaled therapy to be approved in the country. Crew added that Lannett and Respirent also are working to create a generic version of another inhaled powder treatment developed ...
COPD Trial Shows Breztri Aerosphere Significantly Reduces...
WEBby Joana Carvalho, PhD June 30, 2020. Breztri Aerosphere, AstraZeneca ’s triple combination therapy for chronic obstructive pulmonary disease (COPD), significantly reduces the frequency of moderate or severe exacerbations, compared to dual combination therapies, in patients with moderate to very severe forms of …
Trelegy Ellipta Reduces COPD Exacerbations and Improves Lung …
WEBApr 24, 2018 · Results revealed that treatment with the triple therapy Trelegy Ellipta significantly reduced the number of COPD hospitalizations due to severe exacerbations by 34% compared to Anoro Ellipta. Compared to Breo Ellipta, the reduction was of 13%, but this difference was not statistically significant. The …
New Combo Respiratory Therapy for COPD Approved by FDA
WEBJan 17, 2020 · A new double-combination therapy that promotes lung expansion and airway clearance has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of people with lung diseases including chronic obstructive pulmonary disease (COPD) and asthma. The therapy was developed by the Monaghan Medical Corporation and combines two of ...
Spiolto Respimat Fares Well in Comparison with Spiriva Respimat
WEBApr 10, 2018 · The 52-week, Phase 3 DYNAGITO trial (NCT02296138) primarily tested whether Spiolto Respimat reduces the annualized rate of moderate and severe exacerbations beyond the benefits provided by Spiriva Respimat, which contains only the LAMA tiotropium.Scientists recruited COPD patients who had at least one moderate or severe exacerbation needing treatment with systemic glucocorticoids and/or ...
Targeted Lung Denervation for COPD Found Effective, Safe Over 3 …
WEBMar 5, 2021 · Lung function and quality of life remained stable over three years of follow-up among people with chronic obstructive pulmonary disease (COPD) treated with targeted lung denervation (TLD) — a new therapy developed by Nuvaira — according to the results of a clinical trial. That trial, called AIRFLOW-1 (NCT02058459) and sponsored by Nuvaira ...
LupinHaler, generic version of Spiriva HandiHaler, available in US
WEBAug 28, 2023 · In Europe, generics of Boehringer Ingelheim’s Spiriva HandiHaler began launching in 2021, including ones from Glenmark Pharmaceuticals and Phargentis, but these medications haven’t become available in the U.S.. COPD is a chronic lung disease wherein the airways become blocked, leading to progressively worsening disease symptoms that include shortness of breath and wheezing.
COPD Maintenance Therapy Trimbow Wins European Union …
WEBAug 8, 2017 · European Union Approves Chiesi’s COPD Maintenance Therapy Trimbow. by Patrícia Silva, PhD August 8, 2017. The European Union has approved Trimbow as a maintenance treatment for adults with moderate to severe chronic obstructive pulmonary disease. Trimbow, developed by Italy’s Chiesi Group, is …
Skip to content